Literature DB >> 1595393

The no-reflow phenomenon is a post-mortem artifact.

J C de la Torre1, T Fortin, J K Saunders, K Butler, M T Richard.   

Abstract

Post-ischemic reperfusion impairment, ("no-reflow phenomenon"), was studied in rats subjected to 8-30 minutes of global brain ischemia. During ischemia, rapid and complete loss of cerebral blood flow, EEG and 31P-high energy phosphates (ATP/PCr) was observed. Brain intravascular perfusion defects were examined by injecting carbon black intravenously in a group of rats with stable cardiopulmonary function and in another group subjected to rapid thoracotomy and intraarterial infusion of the carbon marker. Results indicate that global brain ischemic or non-ischemic control rats given intraarterial carbon black after thoracotomy had varying degrees of vessel filling defects in brain resulting in "pale tissue areas" suggestive of impaired perfusion (no-reflow). All rats given carbon black intravenously whether global brain ischemic or not, showed normal cerebrovascular filling of the carbon black and absence of "pale tissue areas". In addition, post-ischemic cerebral reperfusion following 8-30 minutes global brain ischemia can reverse neuroelectric, energy metabolite and cerebral blood flow loss in rats whose cardiopulmonary function is not compromised. These findings indicate that the "no-reflow phenomenon" is an agonal or post-mortem artifact observed in the presence of cardiopulmonary failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595393     DOI: 10.1007/bf01400588

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Recovery of cerebral energy metabolism after complete ischemia of one hour's duration.

Authors:  K A Hossmann; K Kobayashi; V Hossmann; P Kleihues
Journal:  Naturwissenschaften       Date:  1973-01

2.  Impaired perfusion following cerebrovascular stasis. A review.

Authors:  E G Fischer
Journal:  Arch Neurol       Date:  1973-12

3.  Studies on mechanisms of impairment of cerebral circulation following ischemia: effect of hemodilution and perfusion pressure.

Authors:  E G Fischer; A Ames 3d
Journal:  Stroke       Date:  1972 Sep-Oct       Impact factor: 7.914

4.  Cerebral ischemia. II. The no-reflow phenomenon.

Authors:  A Ames; R L Wright; M Kowada; J M Thurston; G Majno
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

5.  Temporary regional cerebral ischemia in the cat. A model of hemorrhagic and subcortical infarction.

Authors:  Y Kamijyo; J H Garcia; J Cooper
Journal:  J Neuropathol Exp Neurol       Date:  1977 Mar-Apr       Impact factor: 3.685

6.  Cerebral blood flow immediately following brief circulatory stasis.

Authors:  E G Fischer; A Ames; A V Lorenzo
Journal:  Stroke       Date:  1979 Jul-Aug       Impact factor: 7.914

7.  Ischaemic brain damage in the gerbil in the absence of 'no-reflow'.

Authors:  D E Levy; J B Brierley; F Plum
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-12       Impact factor: 10.154

8.  Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia.

Authors:  J C Grotta; L C Pettigrew; S Allen; A Tonnesen; F M Yatsu; J Gray; J Spydell
Journal:  Stroke       Date:  1985 Sep-Oct       Impact factor: 7.914

9.  Modification of focal cerebral ischemia by cardiac output augmentation.

Authors:  T S Keller; J E McGillicuddy; V A LaBond; G W Kindt
Journal:  J Surg Res       Date:  1985-11       Impact factor: 2.192

10.  Serum cardiac enzymes in stroke.

Authors:  J W Norris; V C Hachinski; M G Myers; J Callow; T Wong; R W Moore
Journal:  Stroke       Date:  1979 Sep-Oct       Impact factor: 7.914

View more
  2 in total

Review 1.  A role for pericytes in coronary no-reflow.

Authors:  Fergus M O'Farrell; David Attwell
Journal:  Nat Rev Cardiol       Date:  2014-04-29       Impact factor: 32.419

Review 2.  Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?

Authors:  Turgay Dalkara; Ethem Murat Arsava
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-10       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.